Sains Malaysiana 53(6)(2024): 1343-1362
http://doi.org/10.17576/jsm-2024-5306-10
Design
and Characterisation of Curcumin-Loaded Nanostructured Lipid Carriers for Safe
and Efficient Topical Drug Delivery in The Treatment of Pressure Ulcer
(Reka
Bentuk dan Pencirian Pembawa Lipid Berstruktur Nano Berpengisi Kurkumin untuk
Penghantaran Ubat Topikal yang Selamat dan Berkesan dalam Rawatan Ulser
Tekanan)
NUR AMIRA MOHD SHAMSUDDIN1,
FAZREN AZMI1, KHAIRANA HUSAIN2, LEONG LEK MUN3 & MOHD HANIF ZULFAKAR1,*
1Centre for Drug Delivery Technology &
Vaccine, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300 Kuala
Lumpur, Malaysia
2Centre for Drug and Herbal Development, Faculty
of Pharmacy, Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia
3Prima Nexus Sdn. Bhd., 28-1B, Jalan Puteri 1/2,
Bandar Puteri, 47100 Puchong, Selangor, Malaysia
Received: 14 February 2024/Accepted: 16 May 2024
Abstract
Pressure ulcers (PU) are chronic lesions with a high prevalence in at-risk populations. Although curcumin has various therapeutic properties, its use as a dermal therapeutic agent is limited by its poor solubility and permeability. This study aimed to develop nanostructured lipid carriers (NLCs) to facilitate the topical use of curcumin as wound healing agent in treating PU. The optimised curcumin-NLCs were characterised for their physicochemical properties, drug release, and skin permeation, while effectiveness and toxicity were investigated via cell viability, scratch assays, and an in vivo skin irritation test. The optimised curcumin-NLCs comprised 3.5% solid lipids, 1% surfactant, and 2% co-surfactant with an average particle size of 134.68±6.0 nm, polydispersity index of 0.248±0.00, zeta potential of −44.94±5.44, percentage of encapsulation efficiency of 93.42±0.32%, and drug loading of 0.11±0.00%. Curcumin-NLCs showed stable physicochemical properties and extended drug release for up to 48 h, with a cumulative release of 77.72% following a first-order kinetics. The formulation exhibited slower curcumin permeation than the free curcumin. Furthermore, the safe and non-toxic curcumin-NLCs were highly effective at 0.98 μM and showed a high rate of wound closure without skin irritation. Collectively, the NLCs developed for topical delivery of curcumin demonstrated prolonged and sustained release and improved wound healing activity, which indicates that curcumin-NLCs are a viable strategy for treating PU.
Keywords: Curcumin; nanostructured
lipid carrier; physicochemical characterisation; pressure ulcers; toxicity
Abstrak
Ulser tekanan (PU) adalah lesi kronik dengan prevalens yang tinggi dalam populasi berisiko. Kurkumin, walaupun mempunyai pelbagai sifat terapeutik, penggunaannya sebagai agen terapeutik kulit adalah terhad akibat keterlarutan dan kebolehtelapan yang lemah. Kajian ini bertujuan untuk membangunkan pembawa lipid berstruktur nano (NLC) untuk memudahkan penggunaan kurkumin sebagai ubat topikal untuk penyembuhan luka dalam merawat PU. Kurkumin-NLC yang dioptimumkan telah dicirikan berdasarkan sifat fizikokimia, pembebasan dadah dan penelapan kulit, manakala keberkesanan dan ketoksikan dianalisis melalui daya maju sel, asai penyembuhan luka dan ujian iritasi kulit in vivo. Kurkumin-NLC yang dioptimumkan terdiri daripada 3.5% lipid pepejal, 1% surfaktan dan 2% surfaktan bersama dengan saiz zarah purata 134.68±6.0 nm, indeks polidispersiti 0.248±0.00, potensi zeta −44.94±5.44, peratusan kecekapan pengkapsulan 93.42±0.32% dan pemuatan dadah 0.11±0.00%. Kurkumin-NLCs menunjukkan sifat fizikokimia yang stabil dan pembebasan ubat yang dilanjutkan sehingga 48 jam dengan pembebasan kumulatif sebanyak 77.72% mengikut kinetik urutan pertama. Formulasi menunjukkan penelapan kurkumin yang lebih perlahan daripada kurkumin bebas. Tambahan pula, kurkumin-NLC yang selamat dan tidak toksik sangat berkesan pada 0.98 μM dan menunjukkan kadar penutupan luka yang tinggi tanpa iritasi kulit. Secara kolektif, NLC yang dibangunkan untuk penghantaran topikal kurkumin menunjukkan pembebesan yang berpanjangan dan berterusan serta aktiviti penyembuhan luka yang lebih baik, ini menunjukkan bahawa kurkumin-NLCs ialah strategi yang berdaya maju untuk merawat PU.
Kata kunci: Ketoksikan; kurkumin;
pembawa lipid berstruktur nano; pencirian fizikokimia, ulser tekanan
REFERENCES
Akbik, D., Ghadiri, M., Chrzanowski,
W. & Rohanizadeh, R. 2014. Curcumin as a wound healing agent. Life Sciences 116(1): 1-7.
doi:10.1016/j.lfs.2014.08.016
Al-Waeli, A.H.A., Chaichan, M.T.,
Kazem, H.A. & Sopian, K. 2019. Evaluation and analysis of nanofluid and
surfactant impact on photovoltaic-thermal systems. Case Studies in Thermal Engineering 13: 100392. doi:10.1016/j.csite.2019.100392
Behbahani, E.S., Ghaedi, M.,
Abbaspour, M. & Rostamizadeh, K. 2017. Optimization and characterization of
ultrasound assisted preparation of curcumin-loaded solid lipid
nanoparticles: Application of central composite design, thermal analysis and
X-ray diffraction techniques. Ultrasonics
Sonochemistry 38: 271-280. doi:10.1016/j.ultsonch.2017.03.013
Bhatt, S., Sharma, J.B., Kamboj, R.,
Kumar, M., Saini, V. & Mandge, S. 2021. Design and optimization of
febuxostat-loaded nano lipid carriers using full factorial design. Turkish Journal of Pharmaceutical Sciences 18(1): 61-67. doi:10.4274/tjps.galenos.2019.32656
Bhattacharya, S. & Mishra, R.
2015. Pressure ulcers: Current understanding and newer modalities of treatment. Indian Journal of Plastic Surgery 48(1): 4-16. doi:10.4103/0970-0358.155260
Borges, A., de Freitas, V., Mateus,
N., Fernandes, I. & Oliveira, J. 2020. Solid lipid nanoparticles as
carriers of natural phenolic compounds. Antioxidants 9(10): 998. doi:10.3390/antiox9100998
Castro, S.R., Ribeiro, L.N.M.,
Breitkreitz, M.C., Guilherme, V.A., Rodrigues da Silva, G.H., Mitsutake, H.,
Alcântara, A.C.S., Yokaichiya,
F., Franco, M.K.K.D., Clemens, D., Kent, B., Lancellotti, M., de Araújo, D.R.
& de Paula, E. 2021. A pre-formulation study of tetracaine
loaded in optimized nanostructured lipid carriers. Scientific Reports 11(1): 21463. doi:10.1038/s41598-021-99743-6
Chuacharoen, T., Prasongsuk, S.
& Sabliov, C.M. 2019. Effect of surfactant concentrations on
physicochemical properties and functionality of curcumin nanoemulsions
under conditions relevant to commercial utilization. Molecules (Basel, Switzerland) 24(15): 2744.
doi:10.3390/molecules24152744
Das, S., Ng, W.K. & Tan, R.B.H.
2012. Are nanostructured lipid carriers (NLCs) better than solid lipid
nanoparticles (SLNs): Development, characterizations and comparative evaluations
of clotrimazole-loaded SLNs and NLCs? European
Journal of Pharmaceutical Sciences 47(1): 139-151.
doi:10.1016/j.ejps.2012.05.010
Elmowafy, M., Samy, A., Raslan,
M.A., Salama, A., Said, R.A., Abdelaziz, A.E., El-Eraky, W., El Awdan, S. &
Viitala, T. 2016. Enhancement of bioavailability and pharmacodynamic effects of
thymoquinone via nanostructured lipid carrier (NLC) formulation. AAPS PharmSciTech 17(3): 663-672.
doi:10.1208/s12249-015-0391-0
Emami, J., Mohiti, H., Hamishehkar,
H. & Varshosaz, J. 2015. Formulation and optimization of solid lipid
nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and
Box-Behnken design. Research in
Pharmaceutical Sciences 10(1): 17-33.
Esposito, E., Ravani, L., Mariani, P., Huang, N., Boldrini, P., Drechsler, M., Valacchi, G., Cortesi, R. & Puglia, C. 2014. Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. European Journal of Pharmaceutics and Biopharmaceutics 86(2): 121-132. doi:10.1016/j.ejpb.2013.12.011.
Gatne, M., Tambe, K., Chaudhary, A. & Ravikanth, K. 2015. Acute dermal irritation study of polyherbal gel Mastilep in rabbits. International Journal of Pharmaceutical Sciences and Research 6: 3473-3476. doi:10.13040/IJPSR.0975-8232.6(8).3473-76.
Gazori, T., Khoshayand, M.R., Azizi,
E., Yazdizade, P., Nomani, A. & Haririan, I. 2009. Evaluation of
Alginate/Chitosan nanoparticles as antisense delivery vector: Formulation,
optimization and in vitro characterization. Carbohydrate
Polymers 77(3): 599-606. doi:10.1016/j.carbpol.2009.02.019
Guhagarkar, S.A., Malshe, V.C. &
Devarajan, P.V. 2009. Nanoparticles of polyethylene sebacate: A new
biodegradable polymer. AAPS PharmSciTech 10(3): 935-942. doi:10.1208/s12249-009-9284-4
Haider, M., Abdin, S.M., Kamal, L.
& Orive, G. 2020. Nanostructured lipid carriers for delivery of
chemotherapeutics: A review. Pharmaceutics 12(3): 288. doi:10.3390/pharmaceutics12030288
Hatcher, H., Planalp, R., Cho, J.,
Torti, F.M. & Torti, S.V. 2008. Curcumin: From ancient medicine to current clinical
trials. Cellular and Molecular Life
Sciences 65(11): 1631-1652. doi:10.1007/s00018-008-7452-4
Housaindokht, M.R. & Nakhaei
Pour, A. 2012. Study the effect of HLB of surfactant on particle size
distribution of hematite nanoparticles prepared via the reverse microemulsion. Solid State Sciences 14(5): 622-625.
doi:10.1016/j.solidstatesciences.2012.01.016
Hussain, Z., Thu, H.E., Ng, S.F.,
Khan, S. & Katas, H. 2017. Nanoencapsulation, an efficient and promising
approach to maximize wound healing efficacy of curcumin: A review of new trends
and state-of-the-art. Colloids and
Surfaces B: Biointerfaces 150: 223-241. doi:10.1016/j.colsurfb.2016.11.036
Kamel, A.E., Fadel, M. & Louis,
D. 2019. Curcumin-loaded nanostructured lipid carriers prepared using peceolTM and olive oil in photodynamic therapy: Development and application in breast
cancer cell line. International Journal
of Nanomedicine 14: 5073-5085. doi:10.2147/IJN.S210484
Khor, H.M., Tan, J., Saedon, N.I.,
Kamaruzzaman, S.B., Chin, A.V., Poi, P.J.H. & Tan, M.P. 2014. Determinants
of mortality among older adults with pressure ulcers. Archives of Gerontology and Geriatrics 59(3): 536-541.
doi:10.1016/j.archger.2014.07.011
Kottner, J., Cuddigan, J., Carville,
K., Balzer, K., Berlowitz, D., Law, S., Litchford, M., Mitchell, P., Moore, Z.,
Pittman, J., Sigaudo-Roussel, D., Yee, C.Y. & Haesler, E. 2020. Pressure
ulcer/injury classification today: An international perspective. Journal of Tissue Viability 29(3):
197-203. doi:10.1016/j.jtv.2020.04.003
Kumbhar, D.D. & Pokharkar, V.B.
2013. Engineering of a nanostructured lipid carrier for the poorly
water-soluble drug, bicalutamide: Physicochemical investigations. Colloids and Surfaces A: Physicochemical and
Engineering Aspects 416: 32-42. doi:10.1016/j.colsurfa.2012.10.031
Lakhani, P., Patil, A., Taskar, P.,
Ashour, E. & Majumdar, S. 2018. Curcumin-loaded nanostructured lipid
carriers for ocular drug delivery: Design optimization and
characterization. Journal of Drug
Delivery Science and Technology 47: 159-166. doi:10.1016/j.jddst.2018.07.010
Liu, M., Wen, J. & Sharma, M.
2020. Solid lipid nanoparticles for topical drug delivery: Mechanisms, dosage
form perspectives, and translational status. Current Pharmaceutical Design 26(27): 3203-3217.
doi:10.2174/1381612826666200526145706
Mulligan, C.N. 2007. Rhamnolipid
biosurfactants: Solubility and environmental issues. In Thermodynamics, Solubility and Environmental Issues, edited by
Letcher, T.M. Elsevier. pp. 279-298.
doi:10.1016/B978-044452707-3/50017-3
Nahak, P., Karmakar, G., Chettri,
P., Roy, B., Guha, P., Besra, S.E., Soren, A., Bykov, A.G., Akentiev, A.V.,
Noskov, B.A. & Panda, A.K. 2016. Influence of lipid core material on
physicochemical characteristics of an ursolic acid-loaded nanostructured
lipid carrier: An attempt to enhance anticancer activity. Langmuir 32(38): 9816-9825. doi:10.1021/acs.langmuir.6b02402
Pradhan, M., Singh, D., Murthy, S.N.
& Singh, M.R. 2015. Design, characterization and skin permeating potential
of Fluocinolone acetonide loaded nanostructured lipid carriers for topical
treatment of psoriasis. Steroids 101:
56-63. doi:10.1016/j.steroids.2015.05.012
Puglia, C., Frasca, G., Musumeci,
T., Rizza, L., Puglisi, G., Bonina, F. & Chiechio, S. 2012. Curcumin loaded
NLC induces histone hypoacetylation in the CNS after intraperitoneal
administration in mice. European Journal
of Pharmaceutics and Biopharmaceutics 81(2): 288-293.
doi:10.1016/j.ejpb.2012.03.015
Rahman, H.S., Rasedee, A., How,
C.W., Abdul, A.B., Zeenathul, N.A., Othman, H.H., Saeed, M.I. & Yeap, S.K.
2013. Zerumbone-loaded nanostructured lipid carriers: Preparation,
characterization, and antileukemic effect. International Journal of Nanomedicine 8: 2769-2781.
doi:10.2147/IJN.S45313
Rapalli, V.K., Kaul, V., Waghule,
T., Gorantla, S., Sharma, S., Roy, A., Dubey, S.K. & Singhvi, G. 2020.
Curcumin loaded nanostructured lipid carriers for enhanced skin retained
topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. European
Journal of Pharmaceutical Sciences 152: 105438.
doi:10.1016/j.ejps.2020.105438
Soleimanifard, M., Sadeghi Mahoonak,
A., Ghorbani, M., Heidari, R. & Sepahvand, A. 2020. The formulation
optimization and properties of novel oleuropein-loaded nanocarriers. Journal of Food Science and Technology 57(1): 327-337. doi:10.1007/s13197-019-04065-1
Sreedharan, S.M. & Singh, R.
2019. Ciprofloxacin functionalized biogenic gold nanoflowers as nanoantibiotics
against pathogenic bacterial strains. International
Journal of Nanomedicine 14: 9905-9916. doi:10.2147/IJN.S224488
Szutkowski, K., Kołodziejska,
Z., Pietralik, Z., Zhukov, I., Skrzypczak, A., Materna, K. & Kozak, M.
2018. Clear distinction between CAC and CMC revealed by high-resolution NMR
diffusometry for a series of bis-imidazolium gemini surfactants in aqueous
solutions. RSC Advances 8(67):
38470-38482. doi:10.1039/c8ra07081d
Toden, S., Okugawa, Y., Jascur, T.,
Wodarz, D., Komarova, N.L., Buhrmann, C., Shakibaei, M., Boland, C.R. &
Goel, A. 2015. Curcumin mediates chemosensitization to 5-fluorouracil through
miRNA-induced suppression of epithelial-to-mesenchymal transition in
chemoresistant colorectal cancer. Carcinogenesis 36(3): 355-367. doi:10.1093/carcin/bgv006
Vijayakumar, A., Baskaran, R., Baek,
J-H., Sundaramoorthy, P. & Yoo, B.K. 2019. In vitro cytotoxicity and bioavailability of ginsenoside-modified
nanostructured lipid carrier containing curcumin. AAPS PharmSciTech 20(2): 88. doi:10.1208/s12249-019-1295-1
Westby, M.J., Dumville, J.C.,
Soares, M.O., Stubbs, N., Norman, G. & Foley, C.N. 2015. Dressings and
topical agents for treating pressure ulcers. Cochrane Database of Systematic Reviews 6(6): CD011947.
doi:10.1002/14651858.CD011947
Wissing, S.A., Kayser, O. &
Müller, R.H. 2004. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 56(9):
1257-1272. doi:10.1016/j.addr.2003.12.002
Yang, G., Wu, F., Chen, M., Jin, J.,
Wang, R. & Yuan, Y. 2019. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a
bile salt for oral delivery of gypenosides. International
Journal of Nanomedicine 14: 2267-2280. doi:10.2147/IJN.S194934
*Corresponding author; email: email: hanifzulfakar@ukm.edu.my
|